Articles | Volume 6, issue 4
J. Bone Joint Infect., 6, 85–90, 2021
https://doi.org/10.5194/jbji-6-85-2021
J. Bone Joint Infect., 6, 85–90, 2021
https://doi.org/10.5194/jbji-6-85-2021
Brief report
27 Jan 2021
Brief report | 27 Jan 2021

Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series

Ernesto Muñoz-Mahamud et al.

Viewed

Total article views: 624 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
433 174 17 624 276 11 11
  • HTML: 433
  • PDF: 174
  • XML: 17
  • Total: 624
  • Supplement: 276
  • BibTeX: 11
  • EndNote: 11
Views and downloads (calculated since 27 Jan 2021)
Cumulative views and downloads (calculated since 27 Jan 2021)

Viewed (geographical distribution)

Total article views: 591 (including HTML, PDF, and XML) Thereof 589 with geography defined and 2 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 22 May 2022
Download
Short summary
A plausible cause of persistent infection after septic hip revision may be the presence of nonviable osteomyelitic bone. We present our initial experience in hip revision for chronic infection in which fluorescent tetracycline bone labeling was used as an additional aid to provide a visual index of surgical bone debridement. In the present series, the use of this technique successfully aided the surgeon to detect the presence of nonviable bone.